Susquehanna International Group, LLP Stoke Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 134,141 shares of STOK stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
134,141
Previous 10,227
1211.64%
Holding current value
$1.54 Million
Previous $138,000
1094.2%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding STOK
# of Institutions
125Shares Held
57.6MCall Options Held
9.3KPut Options Held
35.2K-
Skorpios Trust8.91MShares$102 Million99.85% of portfolio
-
Black Rock Inc. New York, NY5.41MShares$62.2 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.19MShares$59.6 Million22.82% of portfolio
-
Redmile Group, LLC San Francisco, CA4.71MShares$54.2 Million3.79% of portfolio
-
Rtw Investments, LP New York, NY4.65MShares$53.5 Million0.91% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $453M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...